CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra
| Website | https://www.csl.com/ |
| Ticker | CSL |
| Revenue | $14.7 billion |
| Employees | 23,089 (12,867 on RocketReach) |
| Founded | 1916 |
| Address | 655 Elizabeth St, Melbourne, Victoria 3000, AU |
| Phone | +61 3 9387 8454 |
| Fax | +61 3 9389 1434 |
| Industry | Biotechnology Research, Pharmaceuticals, Complex biologicals, Healthcare, Vaccines, Plasma And Plasma Derived Therapeutics |
| Keywords | Biotechnology, Therapeutics, Life Saving Medicines, Vaccines, Influenza Prevention, Plasma, Biologics, Immunology, Rare Diseases, Recombinant Proteins, Immunoglobulins, Drug Development, Pharmaceutical, Dialysis Solutions, Iron Deficiency Treatment, Nephrology, Global Health |
| Competitors | Roche, Novartis, Merck & Co., Inc., Pfizer, Amgen, Regeneron, Gilead Sciences, Biogen, Alexion Pharmaceuticals, Inc., Receptos, a wholly-owned subsidiary of Celgene +50 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular CSL employee's phone or email?
CSL Questions
The CSL annual revenue was $14.7 billion in 2026.
Gordon Naylor is the CEO and Managing Director of CSL.
12,867 people are employed at CSL.
CSL is based in Melbourne, Victoria.
The NAICS codes for CSL are [325, 3254, 32541, 32].
The SIC codes for CSL are [283, 28].
Top CSL Employees
-
Gordon Naylor
CEO and Managing Director at CSL
Ivanhoe, VIC, AU22 -
Karen Neave
Senior Vice President, Chief Risk Officer at CSL
Melbourne, VIC, AU33 -
Michael Wilson
SVP, Head of Global Research at CSL
Melbourne, VIC, AU22 -
Stephen Marlow
EVP and GM, CSL Plasma at CSL
Ivanhoe East, VIC, AU1 -
Tom Reid
Associate General Counsel, APAC, CSL Behring at CSL
Melbourne, VIC, AU33 -
Simon Buensch
Vice President of Manufacturing and Site Head at CSL
Melbourne, VIC, AU1
Related Companies
